3,3',4',5-Tetrachlorosalicylanilide

CHEMBL291338 Phase 4 已批准 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
351.0 g/mol
LogP
5.9
Phase
4

An antimicrobial compound that was historically used in antiseptic soaps and skin preparations to kill bacteria and fungi on the skin's surface. It fell out of widespread use after concerns arose about skin sensitization and photosensitivity reactions in some individuals. Today it is rarely encountered in modern medical or consumer products.

分子量

351.0000 g/mol

LogP

5.90

TPSA

49.30 Ų

Lipinski 五规则

符合

作用机制

Disrupts microbial cell membranes and denatures proteins on contact, producing rapid broad-spectrum antimicrobial activity on skin and wound surfaces.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

机制

Disrupts microbial cell membranes and denatures proteins on contact, producing rapid broad-spectrum antimicrobial activity on skin and wound surfaces.

二维结构

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C(Nc1ccc(Cl)c(Cl)c1)c1cc(Cl)cc(Cl)c1O

InChI

InChI=1S/C13H7Cl4NO2/c14-6-3-8(12(19)11(17)4-6)13(20)18-7-1-2-9(15)10(16)5-7/h1-5,19H,(H,18,20)

Molecular Formula

C13H7Cl4NO2

HBD / HBA

2 / 2

可旋转键数

2

重原子数

20

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

常见问题

An antimicrobial compound that was historically used in antiseptic soaps and skin preparations to kill bacteria and fungi on the skin's surface. It fell out of widespread use after concerns arose about skin sensitization and photosensitivity reactions in some individuals. Today it is rarely encountered in modern medical or consumer products.

Disrupts microbial cell membranes and denatures proteins on contact, producing rapid broad-spectrum antimicrobial activity on skin and wound surfaces.

Yes, 3,3',4',5-Tetrachlorosalicylanilide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL291338. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 14385. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医疗免责声明

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.